In liver neoplasia, almost all cholangiocarcinomas express EpCAM, whereas the majority of hepatocellular carcinomas are EpCAM negative, suggesting that malignant proliferation of hepatocellular carcinoma cells is not related to expression of EpCAM32. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.